LINK:

OBJECTIVES: Upon completion of this activity, the participant should be able to: 

1. Investigate the new class of cardiac myosin inhibitors to gain familiarity.
2. Discuss updates regarding sudden cardiac death evaluation and management.
3. Discuss new recommendations for exercise in HCM population.

 

FACULTY DISCLOSURE: Nitin Kabra, MD has a relevant financial relationship with Bristol Myers Squibb as a speaker.

PLANNERS: The planners have no relevant financial relationship(s) with companies who primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


For assistance please contact Jamie Davidson at [email protected]

Session date: 
10/31/2024 - 12:30pm to 1:30pm CDT
Location: 
Baylor Scott and White Medical Center - Plano
4700 Alliance Blvd
Last 4th or 5th Thursdays, Monthly
Plano, TX 75093
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
    The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 1.00 Attendance
Please login or register for this course.